全文获取类型
收费全文 | 2552篇 |
免费 | 153篇 |
国内免费 | 35篇 |
出版年
2023年 | 6篇 |
2022年 | 30篇 |
2021年 | 58篇 |
2020年 | 11篇 |
2018年 | 35篇 |
2017年 | 24篇 |
2016年 | 102篇 |
2015年 | 224篇 |
2014年 | 225篇 |
2013年 | 246篇 |
2012年 | 297篇 |
2011年 | 229篇 |
2010年 | 120篇 |
2009年 | 96篇 |
2008年 | 113篇 |
2007年 | 84篇 |
2006年 | 57篇 |
2005年 | 93篇 |
2004年 | 84篇 |
2003年 | 91篇 |
2002年 | 65篇 |
2001年 | 48篇 |
2000年 | 29篇 |
1999年 | 14篇 |
1998年 | 16篇 |
1997年 | 11篇 |
1996年 | 14篇 |
1994年 | 6篇 |
1993年 | 12篇 |
1992年 | 10篇 |
1991年 | 12篇 |
1990年 | 14篇 |
1989年 | 11篇 |
1988年 | 15篇 |
1987年 | 6篇 |
1986年 | 11篇 |
1985年 | 6篇 |
1983年 | 6篇 |
1982年 | 7篇 |
1979年 | 7篇 |
1978年 | 6篇 |
1977年 | 8篇 |
1974年 | 8篇 |
1973年 | 6篇 |
1972年 | 6篇 |
1968年 | 7篇 |
1957年 | 9篇 |
1953年 | 5篇 |
1951年 | 7篇 |
1950年 | 5篇 |
排序方式: 共有2740条查询结果,搜索用时 15 毫秒
991.
HE De * DONG Jiuhong * WEN Jianfan XIN Dedong & LU Siqi . Key Laboratory of Cellular Molecular Evolution Kunming Institute of Zoology Chinese Academy of Sciences Kunming China . Graduate School of the Chinese Academy of Sciences Beijing China . Capital University of Medical Sciences Beijing China 《中国科学:生命科学英文版》2005,(6)
In the 1980s some special protozoa were gradually recognized: being eukaryotes, they possess some characteristics between prokaryotes and eukaryotes, for example, lack of eukaryotic organelle such as mi-tochondria, and even 70S ribosomes in some species, containing 16S, 23S rRNA like those of prokaryotes. These protozoa contain diplomonads (e.g. intestinal parasite Giardia), parabasalids (e.g. venereal disease pathogen Trichomonas), microsporidia (e.g. the human pathogen Encephalitozoon), a… 相似文献
992.
993.
利用随机扩增多态性(RAPD-PGR)的方法对48株白念珠菌Candida albicans(Robin)Berkh进行了分析。由初步试验中,随机选用了18种引物,筛选出OPA-14引物,该引物扩增的带型清晰可辨,不同菌株之间扩增的带数6—12条不等,共有6条主带。扩增片段的长度粗略估计在300—2000bp左右。除个别菌株的带型相同以外,大多数菌株之间呈多态性分布,其带型的数目和扩增的片段存在差异。对简单的DNA制备方法,以及RAPD-PCR在临床应用和流行病学调查中的可行性进行了初步探讨。 相似文献
994.
Yu Jin He-Li Sun Simon Ching Lam Zhaohui Su Brian J. Hall Teris Cheung Ming-Zhao Qin Chee H. Ng Yu-Tao Xiang the International Research Collaboration on COVID- 《International journal of biological sciences》2022,18(10):3934
Background: The 2019 novel coronavirus disease (COVID-19) outbreak had a detrimental impact on the mental health of older adults. This study evaluated the central symptoms and their associations in the network of depressive symptoms and compared the network structure differences between male and female older adults in Hong Kong.Methods: Altogether, 3,946 older adults participated in this study. We evaluated the centrality indicators for network robustness using stability and accuracy tests, and examined the potential differences between the structure and connectivity of depression networks in male and female older adults.Results: The overall prevalence of depressive symptoms was 43.7% (95% CI=40.6-46.7%) in males, and 54.8% (95% CI=53.1-56.5%) in females (P<0.05). Sad Mood, Guilt, Motor problems and Lack of Energy were influential symptoms in the network model. Gender differences were found in the network global strength, especially in the following edges: Sad Mood--Guilt, Concentration--Guilt, Anhedonia--Motor, Lack of Energy--Suicide, Appetite--Suicide and Concentration--Suicide.Conclusions: Central symptoms in the depressive symptom network among male and female older adults may be prioritized in the treatment and prevention of depression during the pandemic. 相似文献
995.
996.
Alberto Mantovani Maria Concetta Morrone Carlo Patrono M. Gabriella Santoro Stefano Schiaffino Giuseppe Remuzzi Giovanni Bussolati On behalf of the Covid- Commission of the Accademia Nazionale dei Lincei 《Cell death and differentiation》2022,29(10):1891
Post-acute sequelae of SARS-CoV-2 (PASC), also known as Post-Covid Syndrome, and colloquially as Long Covid, has been defined as a constellation of signs and symptoms which persist for weeks or months after the initial SARS-CoV-2 infection. PASC affects a wide range of diverse organs and systems, with manifestations involving lungs, brain, the cardiovascular system and other organs such as kidney and the neuromuscular system. The pathogenesis of PASC is complex and multifactorial. Evidence suggests that seeding and persistence of SARS-CoV-2 in different organs, reactivation, and response to unrelated viruses such as EBV, autoimmunity, and uncontrolled inflammation are major drivers of PASC. The relative importance of pathogenetic pathways may differ in different tissue and organ contexts. Evidence suggests that vaccination, in addition to protecting against disease, reduces PASC after breakthrough infection although its actual impact remains to be defined. PASC represents a formidable challenge for health care systems and dissecting pathogenetic mechanisms may pave the way to targeted preventive and therapeutic approaches.Subject terms: Infectious diseases, Immunological disorders 相似文献
997.
M.-J. de Boer J. P. Ottervanger A. W. J. vant Hof J. C. A. Hoorntje H. Suryapranata F. Zijlstra Zwolle Myocardial Infarction Study Group 《Netherlands heart journal》2022,30(12):567
BackgroundAlthough the short-term benefit of primary percutaneous coronary intervention (PCI) in elderly patients with ST-elevation myocardial infarction (STEMI) has been demonstrated, the final long-term survival benefit is as yet unknown.AimTo assess the final survival benefit of primary PCI as compared to thrombolytic therapy in patients over 75 years of age.MethodsPatients > 75 years with STEMI were randomised to either primary PCI or thrombolysis. Long-term data on survival were available for all patients.ResultsA total of 46 patients were randomised to primary PCI, 41 to thrombolysis. There were no significant differences in baseline variables. After a maximum of 20 years’ follow-up, all patients had passed away. The patients randomised to thrombolysis died after a mean follow-up duration of 5.2 years (SD 4.9) compared to 6.7 years (SD 4.8) in patients randomised to primary PCI (p = 0.15). Thus, the mean final survival benefit of primary PCI was 1.5 years.ConclusionThe final survival benefit of primary PCI as compared to thrombolysis in elderly patients with STEMI is 1.5 years and their life expectancy increases by 28.8%. 相似文献
998.
Jorge I. Ramírez Sepúlveda Marika Kvarnström Per Eriksson Thomas Mandl Katrine Brække Norheim Svein Joar Johnsen Daniel Hammenfors Malin V. Jonsson Kathrine Skarstein Johan G. Brun the DISSECT consortium Lars Rönnblom Helena Forsblad-d’Elia Sara Magnusson Bucher Eva Baecklund Elke Theander Roald Omdal Roland Jonsson Gunnel Nordmark Marie Wahren-Herlenius 《Biology of sex differences》2017,8(1):25
Background
Despite men being less prone to develop autoimmune diseases, male sex has been associated with a more severe disease course in several systemic autoimmune diseases. In the present study, we aimed to investigate differences in the clinical presentation of primary Sjögren’s syndrome (pSS) between the sexes and establish whether male sex is associated with a more severe form of long-term pSS.Methods
Our study population included 967 patients with pSS (899 females and 68 males) from Scandinavian clinical centers. The mean follow-up time (years) was 8.8 ± 7.6 for women and 8.5 ± 6.2 for men (ns). Clinical data including serological and hematological parameters and glandular and extraglandular manifestations were compared between men and women.Results
Male patient serology was characterized by more frequent positivity for anti-Ro/SSA and anti-La/SSB (p = 0.02), and ANA (p = 0.02). Further, men with pSS were more frequently diagnosed with interstitial lung disease (p = 0.008), lymphadenopathy (p = 0.04) and lymphoma (p = 0.007). Conversely, concomitant hypothyroidism was more common among female patients (p = 0.009).Conclusions
We observe enhanced serological responses and higher frequencies of lymphoma-related extraglandular manifestations in men with pSS. Notably, lymphoma itself was also significantly more common in men. These observations may reflect an aggravated immune activation and a more severe pathophysiological state in male patients with pSS and indicate a personalized managing of the disease due to the influence of the sex of patients with pSS.999.
1000.
The Gene Ontology (GO) is a collaborative effort that provides structured vocabularies for annotating the molecular function, biological role, and cellular location of gene products in a highly systematic way and in a species-neutral manner with the aim of unifying the representation of gene function across different organisms. Each contributing member of the GO Consortium independently associates GO terms to gene products from the organism(s) they are annotating. Here we introduce the Reference Genome project, which brings together those independent efforts into a unified framework based on the evolutionary relationships between genes in these different organisms. The Reference Genome project has two primary goals: to increase the depth and breadth of annotations for genes in each of the organisms in the project, and to create data sets and tools that enable other genome annotation efforts to infer GO annotations for homologous genes in their organisms. In addition, the project has several important incidental benefits, such as increasing annotation consistency across genome databases, and providing important improvements to the GO's logical structure and biological content. 相似文献